IZTC: Invizyne Corp Price-to-Revenue Coefficient
Invizyne Technologies Inc. (IZTC) is implementing innovative cell-free synthesis, streamlining the production of pharmaceuticals and fuels. Exclusive patents and strict EPA and FDA oversight serve as protective barriers. Professional interest in the brand's biocatalysis capabilities is growing rapidly. The historical P/S ratio chart illustrates the market valuation trend, where the current value is 0.00.
Analytical breakdowns for Invizyne (IZTC)
- current price and projected stock value:
- market capitalization information:
- company book value details:
- business debt structure and liquidity details:
Debt to Equity Ratio Invizyne Technologies Inc.|IZTC - Long-Term Debt to Capital|Current Liabilities to Capital Invizyne Corp|IZTC - Company Total Debt|Debt to Net Assets Ratio Invizyne|IZTC - Company Long-Term Liabilities|Amount of Current Liabilities Invizyne Technologies|Immediate Liquidity invizyne.com
- earnings and valuation multiples indicators:
IZTC - Net Profit|Future Profit Invizyne Technologies Inc.|IZTC - P/E Multiple|Future Price to Earnings Multiple Invizyne Technologies Inc|IZTC - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Invizyne|IZTC - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Invizyne Technologies|IZTC - Earnings per share for the last twelve months|Year-over-year earnings per share growth for the last twelve months invizyne.com|IZTC - Earnings per share growth in current year|Expected net earnings per share growth next year Invizyne Technologies Inc.
- sales revenue and business income indicators:
Summary company analytics:invizyne.com, IZTC
The stability of Invizyne Technologies Inc. (IZTC) depends on the successful implementation of cell-free biomanufacturing within the industrial sector, making revenue the primary metric for the market's recognition of its technologies. This indicator compares the total business value with sales volume, utilizing the price-to-sales ratio to determine the extent of the premium paid for future growth and the risk of capital being frozen in a period of stagnation.
Who Invizyne Technologies Inc. competes with
Price-to-Revenue Ratio LIN (linde.com)|P/S Multiple APD (Air Products and Chemicals)|Price-to-Revenue Coefficient DuPont de Nemours (DD)|IP: Market Cap to Revenue|Price-to-Sales Ratio PPG|DOW (Dow Inc.) - Market Cap to Revenue|Price to Sales lyondellbasell.com (LYB)|Price-to-Revenue Ratio International Flavors & Fragrances Inc|Market Cap to Revenue Ratio RPM (RPM International Inc)|P/S Multiple ENTG|SUZ - Price to Sales|Westlake Corporation - Market Cap to Revenue|Market Capitalization-to-Revenue Ratio ALB|ICL: Market Cap to Revenue|NewMarket Corp - Market Cap to Sales Volume|EMN: P/S Multiple|Price to Sales Axalta Corp (AXTA)|ESI (Element Solutions Inc) - P/S Multiple|Market Cap to Revenue sqm.com (SQM)|P/S Multiple CE|SXT (Sensient Technologies Corporation) - Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio Cabot Microelectronics CBT|HWKN: Market Cap to Revenue Ratio|AVNT - Price-to-Revenue Ratio|Price to Sales hbfuller.com|Methanex (MEOH) - Price-to-Revenue Ratio|WDFC (WD-40 Co.) - Price-to-Revenue Ratio|Price-to-Revenue Ratio Chemours Corp|Price to Sales Quaker Chemical Corp. KWR|P/S Multiple PCT|ashland.com (ASH) - Price-to-Revenue Multiple|P/S Multiple NGVT (Ingevity)|Price-to-Revenue Coefficient Innospec Inc (IOSP)|Minerals Tech - P/S Multiple|Price to Sales Daqo Solar|Sylvamo Corporation (SLVM) - Price-to-Revenue Ratio|HUN - Price-to-Revenue Coefficient|Market Cap to Revenue AIN|CLMT: Market Capitalization-to-Revenue Ratio|P/S Multiple ROG|Price-to-Revenue Coefficient Stepan Chemical|Price-to-Revenue Ratio Ecovyst Inc. ECVT|NEO: Market Cap to Revenue Ratio|REX American Resources Corporation - P/S Multiple|ASP Isotopes Inc (ASPI) - Market Cap to Revenue|TROX (Tronox Limited) - Market Cap to Revenue|GSM - Price-to-Revenue Coefficient|WLKP (Westlake Chemical Partners) - P/S Multiple|compassminerals.com (CMP) - Price-to-Revenue Coefficient|Market Cap to Revenue KRO (Kronos Worldwide)|MATV: Price-to-Sales Ratio|LSB Corp - Market Cap to Revenue|Market Cap to Sales Volume BAK (Braskem Corp)|Koppers Holdings Inc. - P/S Multiple|advansix.com (ASIX) - Market Cap to Revenue|OEC: P/S Multiple|Market Cap to Revenue Rayonier Advanced Materials Inc.|ADUR (Aduro Corp) - P/S Multiple|MAGN: Market Capitalization-to-Revenue Ratio|P/S Multiple CLW|TG - Price to Sales|Price-to-Revenue Ratio Core Molding Technologies, Inc. CMT|FF - Market Cap to Revenue|Flexible Solutions International, Inc. - P/S Multiple|Price-to-Revenue Coefficient Alto Ingredients, Inc. ALTO|5eadvancedmaterials.com (FEAM) - Price-to-Revenue Ratio|TSE - Price-to-Revenue Coefficient|Market Cap to Revenue ORGN|NTIC (Northern Technologies International Corporation) - Market Cap to Sales Volume|Price-to-Revenue Ratio LanzaTech Global Inc (LNZA)|YMAT (ymaunivers.com) - Market Capitalization-to-Revenue Ratio|New Era Helium - Market Cap to Revenue|boltthreads.com (BSLK) - Price to Sales|BioNexus Gene Lab Corporation - P/S Multiple|Price-to-Revenue Coefficient Gulf Resources Inc. GURE|cneny.com (CNEY) - Price-to-Revenue Ratio|Market Cap to Revenue Ratio ALTM|Market Cap to Revenue DNMR|Price-to-Revenue Ratio GLT|P/S Multiple GRFX|Price-to-Revenue Coefficient U.S. Silica Holdings, Inc.
